Evidence map›Paper›PMID 35214757›Full record

ArticleVaccines2022

COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study.

Helena Garcia-Llana, Nayara Panizo, Lorena Gandía, Marisa Orti, Elena Giménez-Civera, Claudia Forquet, Luis D'Marco, Maria Jesús Puchades, Mari Sargsyan, Irina Sanchís and 9 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. The Psychosocial Impact of the COVID-19 Pandemic on Chronic Care Patients.Journal of the American Medical Directors Association · 2023
    Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Helena Garcia-LlanaHospital Universitario La Paz-IdiPAZ, Nephrology Department, Universidad Internacional de La Rioja (UNIR), Centro de Estudios Superiores Cardenal Cisneros, Universidad Pontificia de Comillas de Madrid, 28006 Madrid, Spain.
Nayara PanizoNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Lorena GandíaNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Marisa OrtiPreventive Medicine Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Elena Giménez-CiveraNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Claudia ForquetNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Luis D'MarcoUniversidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain.ORCID 0000-0003-0148-891X
Maria Jesús PuchadesNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.ORCID 0000-0001-6927-071X
Mari SargsyanNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Irina SanchísNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Carmen RiberaNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Mª Inés MarcoNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Cristela Moncho FerráNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Carmen María Pérez-BaylachB-Braun AvitumValnefron Massamagrell Dialysis Centre, 46130 Massamagrell, Spain.
Begoña BonillaB-Braun AvitumValnefron Valencia Dialysis Centre, 46021 Valencia, Spain.
Francesc Moncho FrancésNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.ORCID 0000-0003-1812-4098
Elisa Perez-BernatNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Asunción SanchoNephrology Department, Hospital Universitario Dr. Peset, 46017 Valencia, Spain.
Jose Luis GórrizNephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain.
Hospital Clínico Universitario de Valencia · ESB. Braun (Spain) · ESHospital Universitario Doctor Peset · ESHospital Universitario La Paz · ESUniversidad Cardenal Herrera CEU · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.

Indexed as

chronic kidney diseaseCOVID-19psychological distressvaccination

Identifiers

PMID35214757
PMCPMC8878467
OpenAlexW4213318785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.